NEUTRAL news
Advice: HOLD
TechnologyConsumer
Nasdaq 100 Movers: ALNY, MRVL
Markets Feed · 2026-06-08 15:10
· View original source ↗
AI assessment
Alnylam Pharmaceuticals is experiencing a negative stock movement due to its poor performance in the Nasdaq 100, but this news does not provide specific information about their company's operations or financials.
Why HOLD: The headline discusses Alnylam Pharmaceuticals' performance within the broader Nasdaq 100 index and its year-to-date performance. It doesn't offer any insight into the company's operational health, earnings, or other factors that could influence stock value.
Model: qwen2.5:3b · 2026-06-08 15:35
Article (stored locally)
And the worst performing Nasdaq 100 component thus far on the day is Alnylam Pharmaceuticals, trading down 4.7%. Alnylam Pharmaceuticals is lower by about 27.4% looking at the year to date performance.
Two other components making moves today are Take-Two Interactive Software, trading down 2.7%, and Intel, trading up 9.4% on the day.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
This data feed is not available at this time.